Michael Brooks
Förmögenhet: 2 M $ per 2026-05-31
Förmögenhet: 2 M $ per 2026-05-31
Michael Brooks is currently President at Edesa Biotech, Inc. since 2019, with employment at the company starting in 2015.
Former positions include Director-Business Development at Cipher Pharmaceuticals, Inc. from 2010 to 2015, President at Edesa Biotech, Inc. (Old), and Vice President-Corporate Development & Strategy at Edesa Biotech Research, Inc. Education includes an MBA from Rotman School of Management and undergraduate and doctorate degrees from the University of Toronto.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
EDESA BIOTECH, INC. 3,28 % | 2026-05-27 | 291 479 ( 3,28 % ) | 2 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| EDESA BIOTECH, INC. | President | 2019-06-07 |
| Företag | Position | Slut |
|---|---|---|
| CIPHER PHARMACEUTICALS INC. | Företagsledare/Principal | 2015-01-01 |
Edesa Biotech Research, Inc. | Företagsledare/Principal | - |
Edesa Biotech, Inc. (Old)
Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Develops novel non-steroidal molecules for the treatment of allergic contact dermatitis | President | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Cipher Pharmaceuticals, Inc.
Cipher Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Provides laboratory testing and medical imaging services | Health Technology |
Rotman School of Management
Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edesa Biotech, Inc. (Old)
Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Develops novel non-steroidal molecules for the treatment of allergic contact dermatitis | Health Technology |
Edesa Biotech, Inc.
Edesa Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of chronic allergic contact dermatitis | Health Technology |
Edesa Biotech Research, Inc. |
Välj din utgåva
All finansiell information anpassad till den nationella nivån